Point Relief LidoSpot Pain Relieving Patch, 5/pack

Point Relief LidoSpot Pain Relieving Patch, 5/pack

Marsoni

M251S

$38.00

Get it in 3 business days with 1 day shipping. Friday, May 29

Point Relief LidoSpot Pain Relieving Patch, 5/packPoint Relief LidoSpot Pain Relieving Patch, Universal Size (4" x 6"), 5 pack LidoSpot pain relieving patches provide long lasting pain relief from back, neck, joint and muscle aches, soreness, pain and discomfort. Each patch contains the highest permissible amount of lidocaine (4%) without a prescription and 1% menthol. The patches prevent nerves from sending pain impulses to the brain, providing relief when it's needed most. Used after pain treatment

Easy Shipping

Quick Dispatch:

Your Point Relief LidoSpot Pain Relieving Patch, 5/pack orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Point Relief LidoSpot Pain Relieving Patch, 5/pack ships.

Need Help?
Questions about Point Relief LidoSpot Pain Relieving Patch, 5/pack, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Point Relief LidoSpot Pain Relieving Patch, 5/pack in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

The wife struggles with socks. She only like the Nike ones, then they discontinued them, so had to start the search again! Found these, they are expensive just like the Nike, but the size is true, they look great, they are super soft and stretchy. They are light weight and breathable and seem to wick away moisture. She loves these!

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on November 18, 2025